Zeinab Ghasemishahrestani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zeinab Ghasemishahrestani has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ehsan Pashay Ahi
Institute of Biomedicine, Faculty of Medicine, University of Turku, Finland
3 shared publications - Vahid Saqagandomabadi
Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy, Italy
2 shared publications André Luis Souza dos Santos
Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
1 shared publication- Baharuddin Baharuddin
Faculty of Medicine, University of Surabaya, Kalirungkut, Surabaya, 60293, Indonesia
1 shared publication Fabio Cesar Sousa Nogueira
Proteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil; Laboratory of Proteomics, LADETEC, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-598 Rio de Janeiro, RJ, Brazil
1 shared publicationFathimah Andi Rumpa
Sekolah Tinggi Ilmu Kesehatan Kurnia Jaya Persada, Palopo, Sulawesi Selatan 91914, Indonesia; Professional Midwife and Healthcare Provider, Gubeng Surabaya 60284, Indonesia
1 shared publication
Latest Publications
- Open Access
- 19 November 2026
- Published by MDPI AG in Preprints.org
Post-Transcriptional Regulation of Regenerative, Low-Scar, and Fibrotic Wound Repair
Some developmental and tissue-specific wounds heal with minimal fibrosis and substantial restoration of tissue structure. In this review, we examine RNA-level regulation of scarless, low-scar, and regenerative healing in fetal skin, oral mucosa, cornea, zebrafish heart, and other mammalian and fibrotic comparators. We prioritize mechanisms tested causally in vivo and distinguish these findings from associative profiling and extrapolations from normally scar-forming wounds. We focus on microRNA (miRNA) circuits that regulate inflammatory resolution, epithelial migration, fibroblast activation and persistence/exit, extracellular matrix (ECM) deposition and remodeling, and regenerative proliferation. We also assess alternative RNA processing, lncRNAs/circRNAs, RNA-binding proteins, translational control, m6A regulation, and extracellular-vesicle-mediated RNA transfer. We distinguish endogenous post-transcriptional effects from transcriptionally initiated isoform expression and exogenous RNA therapies, and identify TGF-β/SMAD signaling and collagen organization as key downstream convergence points. Across studies, extensive evidence shows that post-transcriptional regulation shapes repair processes, while substantial experimental evidence demonstrates that RNA-level interventions alter fibrosis, scarring, or regenerative responses. However, direct evidence that endogenous post-transcriptional mechanisms determine regenerative versus fibrotic outcomes remains limited. Regenerative cardiac studies implicate specific RNA-associated regulators in injury-induced proliferation and regeneration, but their mechanisms sometimes involve transcriptionally initiated isoform expression, and their effects do not necessarily determine overall repair fate. We therefore propose a phase-resolved framework linking RNA regulators to defined repair processes, tissue-level outcomes, and the strength of causal evidence for regenerative versus fibrotic trajectories.
- 19 November 2026
- Published by MDPI AG in Preprints.org
Open AccessPost-Transcriptional Regulation of Regenerative, Low-Scar, and Fibrotic Wound Repair
Some developmental and tissue-specific wounds heal with minimal fibrosis and substantial restoration of tissue structure. In this review, we examine RNA-level regulation of scarless, low-scar, and regenerative healing in fetal skin, oral mucosa, cornea, zebrafish heart, and other mammalian and fibrotic comparators. We prioritize mechanisms tested causally in vivo and distinguish these findings from associative profiling and extrapolations from normally scar-forming wounds. We focus on microRNA (miRNA) circuits that regulate inflammatory resolution, epithelial migration, fibroblast activation and persistence/exit, extracellular matrix (ECM) deposition and remodeling, and regenerative proliferation. We also assess alternative RNA processing, lncRNAs/circRNAs, RNA-binding proteins, translational control, m6A regulation, and extracellular-vesicle-mediated RNA transfer. We distinguish endogenous post-transcriptional effects from transcriptionally initiated isoform expression and exogenous RNA therapies, and identify TGF-β/SMAD signaling and collagen organization as key downstream convergence points. Across studies, extensive evidence shows that post-transcriptional regulation shapes repair processes, while substantial experimental evidence demonstrates that RNA-level interventions alter fibrosis, scarring, or regenerative responses. However, direct evidence that endogenous post-transcriptional mechanisms determine regenerative versus fibrotic outcomes remains limited. Regenerative cardiac studies implicate specific RNA-associated regulators in injury-induced proliferation and regeneration, but their mechanisms sometimes involve transcriptionally initiated isoform expression, and their effects do not necessarily determine overall repair fate. We therefore propose a phase-resolved framework linking RNA regulators to defined repair processes, tissue-level outcomes, and the strength of causal evidence for regenerative versus fibrotic trajectories.
- Open Access
- 25 May 2026
- Published by MDPI AG in Preprints.org
Telomere Dysfunction and Extracellular Matrix Remodeling
Telomeres and the extracellular matrix (ECM) are often studied as distinct contributors to aging and chronic diseases, yet growing evidence suggests they are deeply interconnected. This review explores the relationship between these two systems in both directions. Telomere shortening, shelterin defects, and loss of telomerase activity can promote senescence, stress responses, myofibroblast transition, and progressive matrix deposition. In turn, stiffness of the ECM, collagen-rich environments, and hyaluronan-linked signaling can shape telomerase activity, proliferative capacity, and telomere-associated damage responses. We bring together evidence from genetic mouse models, mechanistic cell-based studies, and human tissue analyses across the lung, kidney, vasculature, and heart to examine how telomere dysfunction and ECM remodeling influence one another during aging and disease progression. We focus on epithelial cells, fibroblasts, smooth muscle cells, and tubular cells, and discuss key pathways linking telomere biology and ECM regulation, including TRF1, TERT, TGF-β, cGAS–STING, VCAM-1, and mechanotransduction signaling. Taken together, the current findings suggest that telomere dysfunction is not only a marker of tissue aging but it is also an active driver of persistent ECM remodeling and fibrosis, while signals from the ECM can in turn influence telomere maintenance and cellular senescence. This bidirectional relationship provides a clearer framework for understanding how age-related cellular damage progresses into chronic tissue scarring.
- 25 May 2026
- Published by MDPI AG in Preprints.org
Open AccessTelomere Dysfunction and Extracellular Matrix Remodeling
Telomeres and the extracellular matrix (ECM) are often studied as distinct contributors to aging and chronic diseases, yet growing evidence suggests they are deeply interconnected. This review explores the relationship between these two systems in both directions. Telomere shortening, shelterin defects, and loss of telomerase activity can promote senescence, stress responses, myofibroblast transition, and progressive matrix deposition. In turn, stiffness of the ECM, collagen-rich environments, and hyaluronan-linked signaling can shape telomerase activity, proliferative capacity, and telomere-associated damage responses. We bring together evidence from genetic mouse models, mechanistic cell-based studies, and human tissue analyses across the lung, kidney, vasculature, and heart to examine how telomere dysfunction and ECM remodeling influence one another during aging and disease progression. We focus on epithelial cells, fibroblasts, smooth muscle cells, and tubular cells, and discuss key pathways linking telomere biology and ECM regulation, including TRF1, TERT, TGF-β, cGAS–STING, VCAM-1, and mechanotransduction signaling. Taken together, the current findings suggest that telomere dysfunction is not only a marker of tissue aging but it is also an active driver of persistent ECM remodeling and fibrosis, while signals from the ECM can in turn influence telomere maintenance and cellular senescence. This bidirectional relationship provides a clearer framework for understanding how age-related cellular damage progresses into chronic tissue scarring.
- Open Access
- 19 May 2026
- Published by MDPI AG in Preprints.org
Post-Transcriptional Regulation of FGF Signaling: Insights from Musculoskeletal System
Fibroblast growth factor (FGF) signaling plays a pivotal role in the development, maintenance, and regeneration of musculoskeletal tissues. While its transcriptional regulation has been extensively characterized, accumulating evidence indicates that FGF activity is also modulated by a diverse array of post-transcriptional mechanisms. In this review, microRNAs, long non-coding RNAs, alternative splicing, and RNA modifications are examined as key regulators of FGF ligands and receptors across bone, cartilage, muscle, and tooth. Enhancer RNAs and RNA-binding proteins are also discussed as potential modulators of FGF transcript stability and translation. By integrating both established and emerging layers of RNA-level regulation, this review outlines a complex, tissue-specific architecture that fine-tunes FGF signaling in development and repair. To highlight this layered regulatory dimension, the concept of a pathway-specific RNA regulome is introduced, referring to the network of RNA-based mechanisms that modulate signaling cascades, such as FGF, across distinct biological processes. The therapeutic implications of targeting post-transcriptional nodes, particularly through non-coding RNAs and epitranscriptomic marks, are highlighted as promising avenues for future musculoskeletal interventions.
- 19 May 2026
- Published by MDPI AG in Preprints.org
Open AccessPost-Transcriptional Regulation of FGF Signaling: Insights from Musculoskeletal System
Fibroblast growth factor (FGF) signaling plays a pivotal role in the development, maintenance, and regeneration of musculoskeletal tissues. While its transcriptional regulation has been extensively characterized, accumulating evidence indicates that FGF activity is also modulated by a diverse array of post-transcriptional mechanisms. In this review, microRNAs, long non-coding RNAs, alternative splicing, and RNA modifications are examined as key regulators of FGF ligands and receptors across bone, cartilage, muscle, and tooth. Enhancer RNAs and RNA-binding proteins are also discussed as potential modulators of FGF transcript stability and translation. By integrating both established and emerging layers of RNA-level regulation, this review outlines a complex, tissue-specific architecture that fine-tunes FGF signaling in development and repair. To highlight this layered regulatory dimension, the concept of a pathway-specific RNA regulome is introduced, referring to the network of RNA-based mechanisms that modulate signaling cascades, such as FGF, across distinct biological processes. The therapeutic implications of targeting post-transcriptional nodes, particularly through non-coding RNAs and epitranscriptomic marks, are highlighted as promising avenues for future musculoskeletal interventions.
- 21 March 2026
- Published by Elsevier in Pregnancy Hypertension
- Vol. 44, 101454
Re-evaluating the clinical interpretation of sFlt-1/PlGF in diabetes-complicated preeclampsia
- 21 March 2026
- Published by Elsevier in Pregnancy Hypertension
- Vol. 44, 101454
Re-evaluating the clinical interpretation of sFlt-1/PlGF in diabetes-complicated preeclampsia
- 20 November 2025
- Published by Elsevier in Journal of Proteomics
- Vol. 323, 105570
Dinuclear Cu2+-complexes disrupt cellular pathways and rewire the breast cancer proteome
- 20 November 2025
- Published by Elsevier in Journal of Proteomics
- Vol. 323, 105570
Dinuclear Cu2+-complexes disrupt cellular pathways and rewire the breast cancer proteome